The tobacco titan is facing intensifying competition.

Altria (MO) is rated strong sell due to deteriorating fundamentals and an overvalued stock price. MO's premium Marlboro volumes crashed 12.6% in Q4, with overall cigarette volumes declining faster ...

Altria Group shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

In recent months, Altria Group has extended its decades-long streak of dividend increases and expanded its share buyback ...

So, should you buy or sell Altria stock after the recent decline? Before addressing this, if you are looking for an upside with less volatility than holding an individual stock, consider the High ...

Altria is an excellent income play for long-term investors.

When measured against leading competitors, Philip Morris International Inc. (PM), Turning Point Brands, Inc. (TPB), and British American Tobacco p.l.c. (BTI), Altria’s relative undervaluation becomes ...

On the surface, the tobacco giant looks too tempting to ignore. However, some tantalizing metrics may belie reasons for long-term concern. Investors must examine Altria’s dividend sustainability. 10 ...

Altria Group's dividend comprised a major portion of the stock's total return. The shares have a high dividend yield. It's instructive to look back to see how a stock has performed. You can use that ...

U.S.-focused tobacco company Altria Group, Inc. reported its results for the fourth quarter and full-year 2025 yesterday.

Altria is losing ground after Jefferies published bearish coverage on the stock. Jefferies thinks Altria stock could slump to $50 per share over the next year. Altria has been scoring some wins with ...